Literature DB >> 2806295

Arrhythmia patterns in athletes with arrhythmogenic right ventricular dysplasia.

F Furlanello1, R Bettini, A Bertoldi, G Vergara, L Visonà, G B Durante, G Inama, L Frisanco, R Antolini, D Zanuttini.   

Abstract

Arrhythmogenic right ventricular dysplasia (ARVD) is a typical 'silent' arrhythmogenic cardiomyopathy in athletes, with the possibility of normal ventricular performance and life-threatening arrhythmias. We studied 32 athletes (28 M, 4 F), mean age 23 years, follow-up 6.7 years, all previously declared fit for sports activity. They were studied for significant ventricular arrhythmias with LBBB with a final diagnosis of ARVD based on accepted clinical, echocardiographic and angiographic criteria. The study protocol included Holter monitoring (HM), stress test (ST), electrophysiological endocavitary study (EES), 2D echocardiography, RV and LV cardioangiography and coronarography. The most serious arrhythmia appeared at a mean age of 23.4 years, 20 had clinical sustained ventricular tachycardia (VT) (19/20, 95% during sports activity), six non-sustained VT and one ventricular fibrillation (VF). Severe symptoms occurred in 16/32 athletes (50%) during sports activity in 13/16 (81%): presyncope in nine (non-sustained VT in one, sustained VT in eight); syncope in five (sustained VT); aborted sudden death (SD) in one, SD (follow-up) in one. The reproducibility (HM, ST, EES) of clinically severe arrhythmic manifestations which occurred during sports activity was not high. In fact, during sport many factors are at work which may activate several arrhythmogenic mechanisms not easily reproducible in the laboratory. We conclude that a cardioarrhythmological study is mandatory in suspected right ventricular arrhythmias, including morphological study of the RV, to avoid arrhythmic risk during athletic activity.

Entities:  

Mesh:

Year:  1989        PMID: 2806295     DOI: 10.1093/eurheartj/10.suppl_d.16

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  The value of magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Ruzica Maksimović; Okan Ekinci; Christian Reiner; Georg F Bachmann; Petar M Seferović; Arsen D Ristić; Christian W Hamm; Heinz-F Pitschner; Thorsten Dill
Journal:  Eur Radiol       Date:  2005-10-25       Impact factor: 5.315

Review 2.  Outcomes among athletes with arrhythmias and electrocardiographic abnormalities: implications for ECG interpretation.

Authors:  David McClaskey; Daniel Lee; Eric Buch
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

3.  Electrocardiographic changes in 1000 highly trained junior elite athletes.

Authors:  S Sharma; G Whyte; P Elliott; M Padula; R Kaushal; N Mahon; W J McKenna
Journal:  Br J Sports Med       Date:  1999-10       Impact factor: 13.800

4.  Dysplastic conditions of the right ventricular myocardium: Uhl's anomaly vs arrhythmogenic right ventricular dysplasia.

Authors:  L M Gerlis; S C Schmidt-Ott; S Y Ho; R H Anderson
Journal:  Br Heart J       Date:  1993-02

5.  Changes in Exercise Capacity and Ventricular Function in Arrhythmogenic Right Ventricular Cardiomyopathy: The Impact of Sports Restriction during Follow-Up.

Authors:  Sarah Costa; Kristina Koch; Alessio Gasperetti; Deniz Akdis; Corinna Brunckhorst; Guan Fu; Felix C Tanner; Frank Ruschitzka; Firat Duru; Ardan M Saguner
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

6.  Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis.

Authors:  Katherine Giuliano; Paul Scheel; Eric Etchill; Charles D Fraser; Alejandro Suarez-Pierre; Steven Hsu; Ilan S Wittstein; Edward K Kasper; Roberta Florido; Harikrishna Tandri; Hugh Calkins; Chun W Choi; Kavita Sharma; Ahmet Kilic; Nisha A Gilotra
Journal:  ESC Heart Fail       Date:  2022-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.